Back

Perfomance of sudden cardiac death prediction strategies before and after Septal Reduction Strategies in patients with Hypertrophic Cardiomyopathy

27 August 2023 (14:15 - 14:55)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy risk prediction and stratification: death, heart failure, and arrhythmia Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Niccolo' Maurizi

University Hospital of Lausanne, Lausanne (Switzerland)

6 More presentations in this session

Presentation thumbnail
The challenge of risk stratification in hypertrophic cardiomyopathy: clinical, genetic and imaging insights from a quaternary referral centre
Doctor E. Paratz (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Mortality in hypertrophic cardiomyopathy is unrelated to genotype
Doctor J. Bonaventura (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Prediction of cardiac death in patients with hypertrophic cardiomyopathy using RNA-sequencing of plasma small non-coding RNAS
Doctor K. Akita (New York, US)
Abstract Slides Video
Presentation thumbnail
Prediction of acute heart failure events in patients with hypertrophic cardiomyopathy using RNA-Sequencing of plasma small non-coding RNAs
Doctor K. Akita (New York, US)
Abstract Slides Video
Presentation thumbnail
Natural history and predictors of all-cause mortality and major arrhythmic cardiac events in pediatric RASopathy associated hypertrophic cardiomyopathy
Doctor O. Boleti (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy risk prediction and stratification: death, heart failure, and arrhythmia

The Event

Event poster

ESC Congress 2023

27 August 2023 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Long term outcome after septal reduction therapies in patients with hypertrophic cardiomyopathy: insights from the SHaRe registry
thumbnail
Congress Session
Ventricular arrhythmias and sudden cardiac death in cardiomyopathies
thumbnail
Congress Presentation
Effectiveness of contemporary risk stratification in patients with hypertrophic cardiomyopathy: a pilot study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources